Responsibilities of Licensor. All technical responsibility of the Licensor pertinent to this License shall be carried out through Licensor's CSM Program. Licensor for the term of this Agreement shall:
Responsibilities of Licensor. 4.1 Licensor shall use all reasonable efforts:
Responsibilities of Licensor. 9.1 On-Site Assistance. At Our discretion, We may provide on-site assistance upon Your reasonable request and if We have the availability to do so. The cost is five hundred dollars ($500) per day per company representative, plus the cost of travel, food and lodging for Our representatives.
Responsibilities of Licensor. Licensor will have primary responsibility for performing the following tasks and providing the following services:
Responsibilities of Licensor. 4.1 Licensor shall use all reasonable efforts: To make the Licensed Work (s) available by means of the World Wide Web to the Licensee throughout the Subscription Period; To ensure that the Server has sufficient capacity and rate of connectivity to provide the Licensee with a quality of service consistent with current standards in the World Wide Web on-line information provision industry; To restore access to the Licensed Work (s) as soon as possible in the event of an interruption or suspension of the service.
Responsibilities of Licensor. Licensor shall provide the Licensee with a customer number necessary to enable the Licensee to submit the Online Registration Materials. Licensor shall use all reasonable efforts: to make the Licensed Works available by means of the World Wide Web to the Licensee throughout the Subscription Period; to ensure that the Server has sufficient capacity and rate of connectivity to provide the Licensee with a quality of service comparable to current standards in the World Wide Web on-line information provision industry; to restore access to the Licensed Works as soon as possible in the event of an interruption or suspension of the service. Licensor agrees to make available to the Licensee a monthly usage report throughout the Subscription Period detailing the level of use of the Licensed Works by the Licensee's Authorised Users per month, but only to the extent such monthly usage reports are made available by the party hosting the Licensed Works on behalf of the Licensor. This report will not identify individual Authorised User usage, but will be provided in respect of the IP address range(s) given by the Licensee in the Online Registration Materials as a whole. The Licensor will not be able to provide accurate usage reports if the Licensee stores the Licensed Works on any cache or proxy server, or accesses the Licensed Works through an agent gateway
Responsibilities of Licensor. The principal responsibilities of Licensor, in addition to issuing the License hereunder shall be to oversee the development and commercialization of the Licensed Product, including, but not be limited to, the following: (a) the development of Good Manufacturing Practice for manufacturing the Licensed Product; (b) the completion of non-clinical (GLP) studies to support an IND filing; and (c) the preparation and filing of an Investigational New Drug application (the “IND”). Additional funding will be required to complete the necessary clinical trials for FDA approval, for filing of a Biologics License Application (the “BLA”) for the Licensed Products to the FDA and the marketing of the Licensed Products in the U.S
Responsibilities of Licensor. The principal responsibilities of Licensor, in addition to issuing the License hereunder shall be to oversee the development and commercialization of the Licensed Product, including, but not be limited to, the following: (a) the development of Good Manufacturing Practice for manufacturing the Licensed Product; (b) the conduct, submission and defense of (i) necessary clinical trials to register the Licensed Products with the FDA for marketing in the United States (“U.S.”); (ii) the preparation and filing of a New Drug Application (the “NDA”) or Biologics License Application (the “BLA”) for the Licensed Products to the FDA; (iii) the preparation and submission of applications to the FDA for all regulatory pathways for IMT504 (e.g., Orphan Drug Application, Fast Track, Breakthrough Therapy designation, Priority Review, etc.) as agreed to by the JSC; (iv) the marketing of the Licensed Products in the U.S., (v) the use of all commercially reasonable efforts to market the Licensed Products; and (vi) to work with Licensee to accomplish the goals of this Agreement.
Responsibilities of Licensor. LICENSOR shall (a) transfer to LICENSEE or its designee any and all documentation, information, and materials, including without limitation Licensed Technology, that are necessary or useful for the manufacture of Licensed Products, including without limitation the formulation set forth in Exhibit C, (b) provide reasonable support as required by LICENSEE or its designee in developing Licensed Products, including without limitation testing, method development/validation, stability, formulation improvements or other modifications, (c) provide to LICENSEE or its designee, at LICENSEE’s expense, reasonable cooperation as LICENSEE or its designee may request in order to enable manufacture of Licensed Products, including without limitation the formulation set forth in Exhibit C, such assistance to include, without limitation, training personnel of LICENSEE or its designee in relevant processes and test procedures, and (d) upon the written request of LICENSEE, file an ANDA on LICENSEE’s behalf (and at LICENSEE’s expense) with respect to a Licensed Product. In addition, in the event that the practice of the license granted by LICENSOR to LICENSEE under Section 3.1 is found by a court of competent jurisdiction to infringe any intellectual property rights of any Third Party, LICENSOR shall use its best efforts, at LICENSOR’s sole cost and expense, to develop a non-infringing formulation for Compound and will license such formulation to LICENSEE under terms contained herein.
Responsibilities of Licensor. Licensor shall make reasonable commercial efforts to pursue the R&D Activities using the funding provided by Licensee, R&D Activities shall include the pursuit of Patent Rights. Licensor shall provide a team dedicated to the R&D Activities as set forth in the Commercialization Plan.
